Sign In
Get Clay Free →

Suggestions

    Yoav Manaster

    CEO at Progenetics, Co-Founder at EdiTy Therapeutics

    Yoav Manaster is a biotech entrepreneur and scientist with expertise in tumor immunology. He holds a Ph.D. in Tumor Immunology from the Weizmann Institute of Science, which he pursued from 2007 to 2011.1

    Manaster's professional career includes significant roles in the biotech industry:

    1. Co-Founder of EdiTy Therapeutics: He co-founded this company in 2019, which is developing groundbreaking technology for cellular therapies.13

    2. CEO of Progenetics: Since 2015, Manaster has been leading Progenetics, a company specializing in Onco-Diagnostic services. In this role, he has represented various renowned organizations in the field of diagnostics.1

    Manaster is actively involved in the biotech community, often sharing insights about advancements in the field through his LinkedIn posts.234 His work spans areas such as cellular therapies, cancer diagnostics, and genetic research, demonstrating his commitment to advancing medical science and biotechnology.56

    Related Questions

    What is the main focus of EdiTy Therapeutics?
    How did Yoav Manaster transition from Progenetics to EdiTy Therapeutics?
    What are some of the key achievements of Yoav Manaster in the biotech industry?
    What specific technologies is EdiTy Therapeutics developing?
    How does Yoav Manaster's background in tumor immunology influence his work at EdiTy Therapeutics?
    Yoav Manaster
    Yoav Manaster, photo 1
    Yoav Manaster, photo 2
    Add to my network

    Location

    Israel